LLY vs CAH
By Alex · Tickerpine
Eli Lilly and Company vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | CAH |
|---|---|---|
| Price | $1,443.50 | $281.10 |
| Market cap | $1.29T | $64.97B |
| P/E ratio | 46.9 | 36.4 |
| ROE | 86.02% | — |
| Profit margin | 31.90% | 0.70% |
| Revenue growth | 38.60% | 5.50% |
| Dividend yield | 0.48% | 0.73% |
| Beta | 0.39 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs CAH in plain English
- LLY is the bigger company — about 19.8× the market cap of CAH.
- CAH is cheaper on earnings (P/E 36.4 vs 46.9).
- LLY is growing revenue faster (39% vs 6%).
- CAH has the higher dividend yield (0.73% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.